NCI-MATCH cancer trial reaches 6,000-patient tumor sequencing goal 2 years early
The rapid pace of patient enrollment in the National Cancer Institute-Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131) precision medicine cancer treatment trial will result...





